Antibody-Drug Conjugates Analysis

ADC Specialist Sinks on Safety Concerns: What Pharma Teams Need to Know

cancer · 5 min

Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg

FDA · lung cancer · 6 min

ASCO ‘26: Bispecifics, ADCs, and the RAS Revolution Reshape Oncology

prostate cancer · 7 min

AbbVie's Decnupaz Secures FDA Approval for Rare Blood Cancer

FDA · blastic plasmacytoid dendritic cell neoplasm · 5 min

ANVISA Guidelines for Antibody-Drug Conjugates: What You Need to Know

ANVISA · oncology · 9 min

Antibody-Drug Conjugates MEA: Pricing, Access & Adoption Insights 2024

SAHPRA · oncology · 11 min